MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 598072 | Name: Thyroxine I-123

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Thyroxine I-123 is a radioactive iodine.

Chemical Structure

Thyroxine I-123
Thyroxine I-123
CAS#60345-91-7

Theoretical Analysis

MedKoo Cat#: 598072

Name: Thyroxine I-123

CAS#: 60345-91-7

Chemical Formula: C15H11123I4NO4

Exact Mass: 760.6912

Molecular Weight: 760.87

Elemental Analysis: C, 23.68; H, 1.46; I, 64.61; N, 1.84; O, 8.41

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Thyroxine I-123; Thyroxine I 123;
IUPAC/Chemical Name
(S)-2-amino-3-(4-(4-hydroxy-3,5-di(iodo-123I)phenoxy)-3,5-di(iodo-123I)phenyl)propanoic acid
InChi Key
XUIIKFGFIJCVMT-RYQSTNROSA-N
InChi Code
InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1/i16-4,17-4,18-4,19-4
SMILES Code
N[C@@H](CC1=CC([123I])=C(OC2=CC([123I])=C(O)C([123I])=C2)C([123I])=C1)C(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 760.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kang GY, Parks JR, Fileta B, Chang A, Abdel-Rahim MM, Burch HB, Bernet VJ. Thyroxine and triiodothyronine content in commercially available thyroid health supplements. Thyroid. 2013 Oct;23(10):1233-7. doi: 10.1089/thy.2013.0101. Epub 2013 Sep 14. PubMed PMID: 23758055. 2: Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999 Feb 11;340(6):424-9. PubMed PMID: 9971866. 3: Bolk N, Visser TJ, Kalsbeek A, van Domburg RT, Berghout A. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin Endocrinol (Oxf). 2007 Jan;66(1):43-8. PubMed PMID: 17201800. 4: Buitendijk M, Galton VA. Is the kidney a major storage site for thyroxine as thyroxine glucuronide? Thyroid. 2012 Feb;22(2):187-91. doi: 10.1089/thy.2011.0307. Epub 2011 Dec 16. PubMed PMID: 22175240; PubMed Central PMCID: PMC3271371. 5: Wani TA, Zargar S, Majid S, Darwish IA. Analytical Application of Flow Immunosensor in Detection of Thyroxine and Triiodothyronine in Serum. Assay Drug Dev Technol. 2016 Nov;14(9):535-542. Epub 2016 Nov 1. PubMed PMID: 27801595. 6: Braverman LE, Vagenakis A, Downs P, Foster AE, Sterling K, Ingbar SH. Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J Clin Invest. 1973 May;52(5):1010-7. PubMed PMID: 4700481; PubMed Central PMCID: PMC302354. 7: Liewendahl K, Helenius T, Lamberg BA, Mähönen H, Wägar G. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy. Acta Endocrinol (Copenh). 1987 Nov;116(3):418-24. PubMed PMID: 3687325. 8: Hennemann G, Docter R, Krenning EP, Bos G, Otten M, Visser TJ. Raised total thyroxine and free thyroxine index but normal free thyroxine. A serum abnormality due to inherited increased affinity of iodothyronines for serum binding protein. Lancet. 1979 Mar 24;1(8117):639-42. PubMed PMID: 85873. 9: Larsen PR, Atkinson AJ Jr, Wellman HN, Goldsmith RE. The effect of diphenylhydantoin on thyroxine metabolism in man. J Clin Invest. 1970 Jun;49(6):1266-79. PubMed PMID: 4987171; PubMed Central PMCID: PMC322591. 10: Walsh JP. Dissatisfaction with thyroxine therapy - could the patients be right? Curr Opin Pharmacol. 2002 Dec;2(6):717-22. Review. PubMed PMID: 12482736. 11: Cassio A, Cacciari E, Cicognani A, Damiani G, Missiroli G, Corbelli E, Balsamo A, Bal M, Gualandi S. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine? Pediatrics. 2003 May;111(5 Pt 1):1055-60. PubMed PMID: 12728088. 12: Kaptein EM, Moore GE, Ferguson DC, Hoenig M. Thyroxine and triiodothyronine distribution and metabolism in thyroxine-replaced athyreotic dogs and normal humans. Am J Physiol. 1993 Jan;264(1 Pt 1):E90-100. PubMed PMID: 8430792. 13: Huang WS, Cherng SC, Wang CH, Shih BF, Kuo SW, Wu SY. Increased urinary thyroxine sulfate excretion in thyroxine therapy. Endocr J. 1997 Aug;44(4):467-72. Erratum in: Endocr J 1997 Oct;44(5):following 764. PubMed PMID: 9447277. 14: Hillier AP. Autoregulation of thyroxine secretion into bile. J Physiol. 1972 Mar;221(2):471-6. PubMed PMID: 5020987; PubMed Central PMCID: PMC1331344. 15: Senese R, Cioffi F, de Lange P, Goglia F, Lanni A. Thyroid: biological actions of 'nonclassical' thyroid hormones. J Endocrinol. 2014 Apr 22;221(2):R1-12. doi: 10.1530/JOE-13-0573. Print 2014 May. Review. PubMed PMID: 24464019. 16: Jennings PE, O'Malley BP, Griffin KE, Northover B, Rosenthal FD. Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis". Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1645-7. PubMed PMID: 6439358; PubMed Central PMCID: PMC1443837. 17: Banks WA, Kastin AJ, Michals EA. Transport of thyroxine across the blood-brain barrier is directed primarily from brain to blood in the mouse. Life Sci. 1985 Dec 23;37(25):2407-14. PubMed PMID: 4079655. 18: Massart C, Elbadii S, Gibassier J, Coignard V, Rasandratana A. Anti-thyroxine and anti-triiodothyronine antibody interferences in one-step free triiodothyronine and free thyroxine immunoassays. Clin Chim Acta. 2009 Mar;401(1-2):175-6. doi: 10.1016/j.cca.2008.11.001. Epub 2008 Nov 8. PubMed PMID: 19028480. 19: Musa BU, Kumar RS, Dowling JT. Role of thyroxine-binding globulin in the early distribution of thyroxine and triiodothyronine. J Clin Endocrinol Metab. 1969 May;29(5):667-74. PubMed PMID: 4976514. 20: Kalra J, Hart IR. Value of free thyroxine (FT4), free triiodothyronine (FT3), and sensitive thyrotropin (TSH) assay in the assessment of optimal thyroxine therapy. Clin Biochem. 1987 Aug;20(4):265-7. PubMed PMID: 3690828.